UroToday (PeC)
From Kidney Cancer Resource
Contents |
Overview
To view the web-site Click Here
To access the latest Urology news releases from UroToday, go to: Click Here
Articles
22-Oct-2007 - Mohs Micrographic Surgery For Penile Cancer: Management And Long-Term Follow Up
Mohs Micrographic Surgery For Penile Cancer: Management And Long-Term Follow Up
UroToday.com - Although rare in the United States, Penile Cancer is a potentially lethal and psychologically devastating malignancy. Conventional treatment with partial or total Penectomy is rejected by many patients leading to needless morbidity and mortality.
Tissue sparing approaches have been developed to preserve as much functional penile tissue as possible while completely eradicating malignancy. For select patients with low grade disease, local therapies such as radiation, laser vaporization, or excision with a narrow margin produce good results.
Moh's micrographic surgery (MMS) is time intensive and requires the services of a specially trained dermatologic surgeon. However, MMS permits excision of malignant tissues with an ultra-fine margin as determined by intra-operative microscopic examination of sectioned tissue. This process maximizes the amount of normal tissue preserved while completely eradicating Tumour. It is important to keep in mind that the Urologist must remain closely involved in the management of Penile Cancer patients after MMS as urologic complications such as meatal stenosis can arise.
Unfortunately, permission was not granted by our IRB to contact patient in our series to assess their post-operative functional status. Office chart review suggested that most patients were generally satisfied with the procedure but definitive statements on patient satisfaction cannot be made based on our available data. It must also be conceded that our recurrence rate was relatively high. Nevertheless, the long term progression and survival rates were similar to that found in patients treated with more aggressive surgical interventions. For patients with low grade disease, MMS is an attractive tissue-preserving option in the management of Penile Cancer.
Written by
Alan Shindel MD, as part of Beyond the Abstract on UroToday.com. This initiative offers a method of publishing for the professional Urology community. Authors are given an opportunity to expand on the circumstances, limitations etc... of their research by referencing the published abstract.
UroToday - the only Urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: Click Here
To view the original article Click Here
Disclaimer
Kidney Cancer Resource (KCR) is not influenced by sponsors. The information contained herein is not intended as a substitute for the advice of an appropriately qualified and licensed physician or other licensed health care provider. The information provided here is for educational and information purposes only. Early accurate Diagnosis (Dx.) saves lives. Please check with a physician if you suspect you are ill, never ignore Symptoms. To help your health care specialist make an accurate Diagnosis please keep notes of dates, times and details of your Symptoms. We are not offering medical advice nor do we consider links, individuals or articles accessed through this site to be offering medical advice.
E&OE - Errors & Omissions Excepted
As much of the information posted on this Web Site for peoples convenience is of a medical or technical nature, and may be a matter of life or death the E&OE is a Disclaimer showing that to the best of our ability information is accurate and correctly written or transcribed. Before acting on information on this site you are responsible for checking it with your relevant medical team. We can not be held responsible for any Errors & Omissions made; nor for information on links and articles provided in good faith.
